Invasive Micropapillary Urothelial Carcinoma

subtype

Identifier: CI-CAN-00002959
Entity page: /cancer/invasive-micropapillary-urothelial-carcinoma ↗
Edges: 17

Neighbours: 13 drugs4 trials
Drawn: 17 of 17 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Invasive Micropapillary Urothelial Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived13 of 13
→ investigated in trials for	Durvalumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Invasive Micropapillary Urothelial Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants

Invasive Micropapillary Urothelial Carcinoma studied in …STUDIED_INderived4 of 4
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 4 trials mapped (3 active)	—	—	Invasive Bladder Micropapillary Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 4 trials mapped (3 active)	—	—	Invasive Bladder Micropapillary Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03744793Phase 2 · active not recruiting Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer · condition mapped ALIAS · 4 trials mapped (3 active)	—	—	Invasive Bladder Micropapillary Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03912818Phase 2 · terminated Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ALIAS · 4 trials mapped (3 active)	—	—	Invasive Bladder Micropapillary Urothelial Carcinoma	1	Observed	clinicaltrials	graph →

Invasive Micropapillary Urothelial Carcinoma studied in …STUDIED_INderived4 of 4

→ studied in

NCT03866382Phase 2 · recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 4 trials mapped (3 active)

—

Invasive Bladder Micropapillary Urothelial Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT02812420early Phase 1 · active not recruiting

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 4 trials mapped (3 active)

—

Invasive Bladder Micropapillary Urothelial Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT03744793Phase 2 · active not recruiting

Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer · condition mapped ALIAS · 4 trials mapped (3 active)

—

Invasive Bladder Micropapillary Urothelial Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT03912818Phase 2 · terminated

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ALIAS · 4 trials mapped (3 active)

—

Invasive Bladder Micropapillary Urothelial Carcinoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains